We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-3.62%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$367M
AUM Growth
-$21M
Cap. Flow
-$20.3M
Cap. Flow %
-5.53%
Top 10 Hldgs %
70.94%
Holding
38
New
2
Increased
6
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.31M
2
IIIN icon
Insteel Industries
IIIN
+$2.02M
3
LVTX
LAVA Therapeutics
LVTX
+$1.6M
4
FATE icon
Fate Therapeutics
FATE
+$863K
5
CRBU icon
Caribou Biosciences
CRBU
+$623K

Top Sells

Rank Stock Value
1
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$2.3M
2
ABBV icon
AbbVie
ABBV
+$1.64M
3
ALL icon
Allstate
ALL
+$1.45M
4
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$1.13M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 35.88%
2 Utilities 30.27%
3 Industrials 12.87%
4 Communication Services 6.7%
5 Financials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
26
MannKind Corp
MNKD
$1.25B
$800K 0.22%
195,073
– –
IGMS
27
DELISTED
IGM Biosciences
IGMS
$756K 0.21%
55,000
– –
OGN icon
28
Organon & Co
OGN
$3.55B
$740K 0.2%
31,470
– –
MASS icon
29
908 Devices
MASS
$302M
$587K 0.16%
68,286
– –
VTRS icon
30
Viatris
VTRS
$20.1B
$573K 0.16%
59,539
-733
-1% -$8.13K
CRBU icon
31
Caribou Biosciences
CRBU
$164M
$531K 0.14%
+100,000
New +$623K
PSNL icon
32
Personalis
PSNL
$1.61B
$414K 0.11%
150,000
+100,000
+200% +$281K
RLI icon
33
RLI Corp
RLI
$5.66B
$319K 0.09%
4,800
– –
WBD icon
34
Warner Bros
WBD
$67.4B
$224K 0.06%
14,811
+301
+2% +$4.28K
AMYT
35
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
– –
-315,182
Closed -$2.3M
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Bruce & Co held 38 positions worth $367M, down 5.4% from $388M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bruce & Co withdrew a net $20.3M in Q1 2023, closing 1 position and reducing 17 holdings. Its most notable exit was Amryt Pharma plc American Depositary Shares, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 36% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Kodiak Sciences worth $2.93M.

  • Bruce & Co's largest Q1 2023 buy was Kodiak Sciences: 473,000 shares worth $2.93M.
  • Bruce & Co added most to Insteel Industries in Q1 2023, an estimated $2.02M increase.
  • Bruce & Co's biggest Q1 2023 reduction was AbbVie, cutting an estimated $1.64M.
  • Bruce & Co fully exited Amryt Pharma plc American Depositary Shares in Q1 2023, selling an estimated $2.3M.
  • Bruce & Co's ten largest holdings make up 71% of its $367M portfolio in Q1 2023.
  • Bruce & Co opened 2 new positions and closed 1 in Q1 2023.
  • Bruce & Co's portfolio value fell 5.4% quarter-over-quarter to $367M.

Based on Bruce & Co's 13F filing for Q1 2023, filed 12 May 2023.